Stock listing
KRX:365270 Curacle Co., Ltd. (큐라클) 주가
Follow Curacle Co., Ltd. into a list and get an email when it puts out news.
Share price · KRX:365270
₩7,100.00 KRW -250.00 (-3.4%)
Close on Nov 20, 2026
- Day range
- ₩6,950.00 – ₩7,740.00 KRWNov 20, 2026
- Volume
- 55,160 sharesNov 20, 2026
- Market cap
- ₩157.3B KRWAt the close on Nov 20, 2026 · price × 22.16M shares outstanding
- 52-week range
- ₩4,400.00 – ₩20,750.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩527.3M KRWMedian day 54,808 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:365270 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩7,100.00 | -250.00 | -3.4% | ₩7,050.00 | ₩7,740.00 | ₩6,950.00 | 55,160 | |
| ₩7,350.00 | -280.00 | -3.7% | ₩7,540.00 | ₩7,765.00 | ₩7,320.00 | 71,919 | |
| ₩7,630.00 | +20.00 | +0.3% | ₩7,610.00 | ₩7,900.00 | ₩7,500.00 | 26,589 | |
| ₩7,610.00 | -350.00 | -4.4% | ₩7,950.00 | ₩8,140.00 | ₩7,600.00 | 23,664 | |
| ₩7,960.00 | -180.00 | -2.2% | ₩8,220.00 | ₩8,270.00 | ₩7,960.00 | 24,131 | |
| ₩8,140.00 | -80.00 | -1.0% | ₩8,020.00 | ₩8,250.00 | ₩8,010.00 | 16,825 | |
| ₩8,220.00 | +180.00 | +2.2% | ₩8,040.00 | ₩8,300.00 | ₩8,040.00 | 39,822 | |
| ₩8,040.00 | +150.00 | +1.9% | ₩7,960.00 | ₩8,300.00 | ₩7,910.00 | 24,388 | |
| ₩7,890.00 | +380.00 | +5.1% | ₩7,270.00 | ₩8,210.00 | ₩7,270.00 | 60,609 | |
| ₩7,510.00 | -490.00 | -6.1% | ₩7,570.00 | ₩7,690.00 | ₩7,250.00 | 66,346 | |
| ₩8,000.00 | -190.00 | -2.3% | ₩7,950.00 | ₩8,460.00 | ₩7,730.00 | 64,959 | |
| ₩8,190.00 | +360.00 | +4.6% | ₩7,990.00 | ₩8,290.00 | ₩7,550.00 | 56,293 | |
| ₩7,830.00 | -110.00 | -1.4% | ₩8,000.00 | ₩8,160.00 | ₩7,700.00 | 32,086 | |
| ₩7,940.00 | -10.00 | -0.1% | ₩7,940.00 | ₩8,140.00 | ₩7,850.00 | 14,143 | |
| ₩7,950.00 | -70.00 | -0.9% | ₩8,010.00 | ₩8,160.00 | ₩7,840.00 | 14,225 | |
| ₩8,020.00 | -190.00 | -2.3% | ₩8,190.00 | ₩8,290.00 | ₩7,770.00 | 40,929 | |
| ₩8,210.00 | +280.00 | +3.5% | ₩7,940.00 | ₩8,300.00 | ₩7,940.00 | 35,583 | |
| ₩7,930.00 | -300.00 | -3.6% | ₩8,300.00 | ₩8,490.00 | ₩7,890.00 | 56,157 | |
| ₩8,230.00 | -440.00 | -5.1% | ₩8,580.00 | ₩8,760.00 | ₩8,230.00 | 27,995 | |
| ₩8,670.00 | -210.00 | -2.4% | ₩8,880.00 | ₩9,000.00 | ₩8,600.00 | 70,661 | |
| ₩8,880.00 | -220.00 | -2.4% | ₩9,350.00 | ₩9,350.00 | ₩8,860.00 | 31,652 | |
| ₩9,100.00 | +70.00 | +0.8% | ₩9,030.00 | ₩9,360.00 | ₩9,030.00 | 39,183 | |
| ₩9,030.00 | -460.00 | -4.8% | ₩9,470.00 | ₩9,470.00 | ₩8,800.00 | 61,264 | |
| ₩9,490.00 | +110.00 | +1.2% | ₩9,440.00 | ₩9,490.00 | ₩9,120.00 | 39,858 | |
| ₩9,380.00 | +930.00 | +11.0% | ₩8,700.00 | ₩9,560.00 | ₩8,440.00 | 99,411 | |
| ₩8,450.00 | -480.00 | -5.4% | ₩8,450.00 | ₩8,850.00 | ₩8,200.00 | 79,957 | |
| ₩8,930.00 | +70.00 | +0.8% | ₩8,990.00 | ₩9,090.00 | ₩8,650.00 | 31,692 | |
| ₩8,860.00 | -130.00 | -1.4% | ₩9,130.00 | ₩9,130.00 | ₩8,470.00 | 54,509 | |
| ₩8,990.00 | -780.00 | -8.0% | ₩9,770.00 | ₩9,900.00 | ₩8,900.00 | 93,488 | |
| ₩9,770.00 | -280.00 | -2.8% | ₩10,160.00 | ₩10,200.00 | ₩9,650.00 | 94,503 | |
| ₩10,050.00 | -70.00 | -0.7% | ₩10,370.00 | ₩10,370.00 | ₩9,930.00 | 29,604 | |
| ₩10,120.00 | -80.00 | -0.8% | ₩10,110.00 | ₩10,480.00 | ₩10,020.00 | 47,009 | |
| ₩10,200.00 | -180.00 | -1.7% | ₩10,460.00 | ₩10,460.00 | ₩10,020.00 | 42,377 | |
| ₩10,380.00 | +80.00 | +0.8% | ₩10,410.00 | ₩10,670.00 | ₩10,180.00 | 55,189 | |
| ₩10,300.00 | +460.00 | +4.7% | ₩10,000.00 | ₩10,400.00 | ₩9,740.00 | 71,234 | |
| ₩9,840.00 | +170.00 | +1.8% | ₩9,690.00 | ₩9,920.00 | ₩9,500.00 | 67,879 | |
| ₩9,670.00 | +100.00 | +1.0% | ₩9,570.00 | ₩9,990.00 | ₩9,400.00 | 35,186 | |
| ₩9,570.00 | +350.00 | +3.8% | ₩9,300.00 | ₩9,670.00 | ₩9,160.00 | 100,867 | |
| ₩9,220.00 | +100.00 | +1.1% | ₩9,120.00 | ₩9,450.00 | ₩9,020.00 | 84,514 | |
| ₩9,120.00 | -20.00 | -0.2% | ₩9,350.00 | ₩9,360.00 | ₩8,980.00 | 55,106 | |
| ₩9,140.00 | -140.00 | -1.5% | ₩9,280.00 | ₩9,540.00 | ₩9,130.00 | 42,533 | |
| ₩9,280.00 | +80.00 | +0.9% | ₩9,130.00 | ₩9,610.00 | ₩9,100.00 | 27,247 | |
| ₩9,200.00 | -160.00 | -1.7% | ₩9,300.00 | ₩9,340.00 | ₩9,070.00 | 25,715 | |
| ₩9,360.00 | +150.00 | +1.6% | ₩9,210.00 | ₩9,490.00 | ₩9,060.00 | 24,698 | |
| ₩9,210.00 | -140.00 | -1.5% | ₩9,300.00 | ₩9,450.00 | ₩9,100.00 | 27,668 | |
| ₩9,350.00 | -350.00 | -3.6% | ₩9,400.00 | ₩9,690.00 | ₩9,230.00 | 72,376 | |
| ₩9,700.00 | -130.00 | -1.3% | ₩10,100.00 | ₩10,100.00 | ₩9,400.00 | 36,107 | |
| ₩9,830.00 | +80.00 | +0.8% | ₩9,950.00 | ₩10,110.00 | ₩9,670.00 | 42,580 | |
| ₩9,750.00 | -160.00 | -1.6% | ₩9,920.00 | ₩10,480.00 | ₩9,750.00 | 61,778 | |
| ₩9,910.00 | -140.00 | -1.4% | ₩10,060.00 | ₩10,230.00 | ₩9,830.00 | 46,330 | |
| ₩10,050.00 | +400.00 | +4.1% | ₩9,700.00 | ₩10,350.00 | ₩9,700.00 | 76,619 | |
| ₩9,650.00 | -300.00 | -3.0% | ₩10,030.00 | ₩10,460.00 | ₩9,590.00 | 113,835 | |
| ₩9,950.00 | -380.00 | -3.7% | ₩10,390.00 | ₩10,640.00 | ₩9,940.00 | 78,725 | |
| ₩10,330.00 | -210.00 | -2.0% | ₩10,540.00 | ₩10,950.00 | ₩10,220.00 | 54,131 | |
| ₩10,540.00 | -250.00 | -2.3% | ₩10,790.00 | ₩10,790.00 | ₩10,170.00 | 63,850 | |
| ₩10,790.00 | +180.00 | +1.7% | ₩10,270.00 | ₩10,820.00 | ₩10,270.00 | 66,679 | |
| ₩10,610.00 | -420.00 | -3.8% | ₩11,030.00 | ₩11,100.00 | ₩10,530.00 | 56,229 | |
| ₩11,030.00 | +70.00 | +0.6% | ₩10,970.00 | ₩11,520.00 | ₩10,500.00 | 91,569 | |
| ₩10,960.00 | +10.00 | +0.1% | ₩10,870.00 | ₩11,000.00 | ₩10,300.00 | 50,622 | |
| ₩10,950.00 | +110.00 | +1.0% | ₩10,840.00 | ₩11,100.00 | ₩10,520.00 | 82,731 | |
| ₩10,840.00 | -830.00 | -7.1% | ₩11,050.00 | ₩11,430.00 | ₩10,800.00 | 118,339 | |
| ₩11,670.00 | +780.00 | +7.2% | ₩11,150.00 | ₩11,720.00 | ₩10,700.00 | 162,418 |
Splits
1 split · KRX:365270 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1.1763-for-1 | Split |
- Ticker
- KRX:365270
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
Curacle Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
Valuation
EV/sales 16.3× against a median of 13.6×: 5th lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩134.3B KRW
- P/E
- Loss
- EV/sales
- 16.3×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 3.4×
- Gross margin
- 88.2%
- Operating margin
- −99.3%
- Net margin
- −92.1%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Curacle Co., Ltd. · KRX:365270 | US$116.9M | US$99.81M | n/a | 16.3× | n/a | 3.4× | −92.1% | 0.0× | n/a |
| Satellos Bioscience Inc · TSX:MSCL | US$121.9M | US$69.23M | n/a | n/a | n/a | 2.5× | n/a | 0.0× | 0.49 |
| Alar Pharmaceuticals Inc · TPEX:6785 | US$121.0M | US$51.66M | n/a | 568× | n/a | 1.7× | n/a | 0.0× | n/a |
| CANbridge Pharmaceuticals Inc. · HKEX:1228 | US$120.4M | US$111.5M | n/a | 13.3× | n/a | n/a | −146.4% | n/a | n/a |
| Atrium Therapeutics, Inc. · NASDAQ:RNA | US$118.4M | −US$113.0M | n/a | −2.9× | n/a | 0.6× | −229.7% | 0.0× | 0.76 |
| Adagene, Inc. · NASDAQ:ADAG | US$118.2M | −US$3.65M | n/a | −0.5× | n/a | 1.1× | −229.6% | 0.1× | 1.43 |
| STCube, Inc. · KRX:052020 | US$117.7M | US$71.99M | n/a | 13.6× | n/a | 2.6× | −338.7% | 0.0× | n/a |
| PegBio Co., Ltd. Class H · HKEX:2565 | US$117.2M | US$55.83M | n/a | n/a | n/a | 2.9× | n/a | 0.0× | n/a |
| enGene Therapeutics Inc. · NASDAQ:ENGN | US$116.6M | −US$149.7M | n/a | n/a | n/a | 0.5× | n/a | 0.0× | 1.82 |
| Sinew Pharma, Inc. · TPEX:6634 | US$114.4M | US$84.21M | n/a | 59,054× | n/a | 3.6× | n/a | 0.0× | n/a |
| Armata Pharmaceuticals, Inc. · AMEX:ARMP | US$112.7M | US$346.0M | n/a | 45.8× | n/a | n/a | n/a | n/a | 0.97 |
| Median of the others | US$117.9M | US$62.53M | 13.6× | 2.1× | −229.6% | 0.0× | 0.97 |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.10M | 1.63B | 10.3B | 3.58B | 6.25B | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | ||||
| Gross profit | 7.10M | 1.63B | 10.3B | 3.58B | 6.25B | 0 | 0 | 0 |
| Research and development | 3.39B | 607.3M | 6.24B | 4.22B | ||||
| Selling, general and administrative | 10.2B | 13.5B | 20.0B | 14.1B | 12.1B | 1.55B | 1.47B | 1.79B |
| Operating income | -16.5B | -12.6B | -10.5B | -12.0B | -6.84B | -28.7B | -14.1B | -1.79B |
| Depreciation and amortization | 610.9M | 581.1M | 555.5M | 438.0M | 328.7M | 265.9M | 132.1M | |
| EBITDA | -15.9B | -12.1B | -9.95B | -11.5B | -6.52B | -28.4B | -14.0B | |
| Interest expense | 1.60B | 2.45B | 1.35B | 207.9M | 22.0M | 23.5M | 0 | 0 |
| Income before tax | -18.1B | -14.9B | -11.6B | -11.4B | -6.68B | -28.6B | -14.0B | -2.83B |
| Net income | -18.1B | -14.9B | -11.6B | -11.4B | -6.68B | -28.6B | -14.0B | -2.83B |
| Earnings per share, basic | -862.14 | -912.17 | -710.87 | -823.75 | -427.75 | -1,878.11 | -1,047.41 | -211.68 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.04B | 3.98B | 12.8B | 8.51B | 10.4B | 443.0K | 392.0K | |
| Short-term investments | 20.0B | 26.4B | 28.0B | 23.1B | 35.0B | 4.75B | 8.75B | 7.02B |
| Receivables | 0 | 1.10B | 888.7M | 169.2M | 9.61M | 21.6M | ||
| Current assets | 24.5B | 32.4B | 44.5B | 33.4B | 46.5B | 10.7B | 13.6B | 10.1B |
| Property, plant and equipment | 21.2B | 18.3B | 1.53B | 1.40B | 120.0M | |||
| Total assets | 53.2B | 59.3B | 69.8B | 55.7B | 65.5B | 12.7B | 15.5B | 10.6B |
| Current liabilities | 12.8B | 21.0B | 10.2B | 1.37B | 2.38B | 5.26B | 321.2M | 109.4M |
| Long-term debt | 3.00B | 8.00B | 10.2B | 8.00B | 8.00B | 0 | 29.2B | 12.1B |
| Total debt | 580.5M | 29.9B | ||||||
| Total liabilities | 16.1B | 29.3B | 27.9B | 9.49B | 10.5B | 5.96B | 30.3B | 12.2B |
| Shareholders' equity | 37.1B | 30.0B | 41.9B | 46.2B | 55.0B | 6.73B | -14.8B | -1.68B |
| Shares outstanding | 21.0M | 16.3M | 16.3M | 13.8M | 15.6M | 15.2M | 13.4M | 13.4M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -13.4B | -9.51B | -9.39B | -11.2B | -3.84B | -6.28B | -4.45B | -1.75B |
| Capital spending | -23.6M | -318.0M | -128.9M | -3.55B | -17.6B | -409.0M | -608.6M | -21.8M |
| Free cash flow | -13.5B | -9.83B | -9.52B | -14.8B | -21.4B | -6.69B | -5.06B | -1.77B |
| Cash from investing | -29.4M | -6.04B | 8.44B | -48.1B | 3.50B | -2.40B | -7.05B | |
| Cash from financing | 59.1M | 19.8B | 661.8M | 56.8B | 3.92B | 8.62B | 11.0B | |
| Share buybacks | 114.5M | 56.3M | 735.6M | 51.8B | 4.05B | 8.70B | 11.0B | |
| Change in cash | 58.4M | -8.86B | 4.33B | -1.93B | 4.90B | 1.14B | 1.77B | 2.20B |
Cap table
Built by 6ix from Curacle Co., Ltd.’s releases
- Common shares
- 22,156,992
- Fully diluted
- 22,156,992
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 22,156,992 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 22,156,992 |
Log in to ask 6ix AI your own questions about Curacle Co., Ltd.